Australia markets closed

Esperion Therapeutics, Inc. (ESPR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
6.28-0.08 (-1.26%)
As of 01:41PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts10101010
Avg. Estimate-0.92-0.9-3.63-1.63
Low estimate-0.99-1-3.94-3.79
High estimate-0.84-0.8-3.292.7
Year ago EPS-1.67-2.62-9.31-3.63
Revenue estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts9999
Avg. Estimate18.83M21.02M83.49M216.81M
Low estimate14.3M15M74.5M127.4M
High estimate20.91M24.72M93.45M613.41M
Year ago sales42.18MN/A78.45M83.49M
Sales growth (year/est)-55.40%N/A6.40%159.70%
Earnings history29/06/202129/09/202130/12/202130/03/2022
Est. EPS-1.84-2.8-2.27-1.04
Actual EPS-1.67-2.62-1.77-0.93
Difference0.170.180.50.11
Surprise %9.20%6.40%22.00%10.60%
EPS trendCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Current estimate-0.92-0.9-3.63-1.63
7 days ago-0.92-0.9-3.63-1.63
30 days ago-0.92-0.9-3.63-1.63
60 days ago-0.98-0.95-3.86-2.3
90 days ago-1-0.91-3.81-2.18
EPS revisionsCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesESPRIndustrySector(s)S&P 500
Current qtr.44.90%N/AN/AN/A
Next qtr.65.60%N/AN/AN/A
Current year61.00%N/AN/AN/A
Next year55.10%N/AN/AN/A
Next 5 years (per annum)16.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A